Back To Blog

What CITI Program is Reading – January 18, 2024

“What CITI Program is Reading” is our biweekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for upcoming editions and more information from CITI Program.


vertex office building
FDA expands approval of CRISPR-based medicine to treat beta thalassemia Source: STAT The FDA approved a CRISPR-based medicine to treat beta thalassemia, an inherited blood disorder. It’s the same potentially curative therapy cleared by the FDA to treat sickle cell disease.

(Login may be required) Read The Full Article

business woman
New NIH chief opens up about risky pathogens, postdoc salaries and the year ahead Source: Nature Nature talks to Monica Bertagnolli about hot-button issues and her top priorities for 2024. Read The Full Article
black and white graphic
A Flaw in Millions of Apple, AMD, and Qualcomm GPUs Could Expose AI Data Source: Wired Patching every device affected by the LeftoverLocals vulnerability—which includes some iPhones, iPads, and Macs—may prove difficult.

(Login may be required) Read The Full Article

icon of newsletter
Cleaning Tasks and Products and Asthma Among Health Care Professionals Source: Journal of Occupational and Environmental Medicine We estimated asthma prevalence by professional group and explored associations of self-reported asthma with job-exposure matrix–based cleaning tasks/products in a representative Texas sample of 9914 physicians, nurses, respiratory/occupational therapists, and nurse aides. Read The Full Article
hands typing on laptop with text in background
Plagiarism Detection Tools Offer a False Sense of Accuracy Source: The Markup The tools that likely brought down Harvard president Claudine Gay are improperly used on students all the time. Read The Full Article
group of men
Doing your own research is a good way to end up being wrong Source: The Washington Post The mantra of the internet era is that the abundance of information allows people to be better informed. That’s not always true.

(Login may be required) Read The Full Article

zepbound tube
What Eli Lilly’s Zepbound reveals about the intricate process of naming drugs today Source: STAT The story behind the Zepbound moniker offers insight into the marketing differences between the U.S. and Europe, as well as how drug names are developed today.

(Login may be required) Read The Full Article

icon of newsletter
Challenges meeting U.S. ClinicalTrials.gov reporting requirements Source: CTTI Timely, accurate, and complete registration and reporting of summary results information for applicable clinical trials on ClinicalTrials.gov is an important part of providing patients, providers, researchers, and the public with access to information about clinical trials and their results. Read The Full Article
group of surgeons
Brain Navi’s neurosurgical robot used in 100th surgical procedure Source: Medical Device Network Brain Navi plans to submit a 510(k) application to the US Food and Drug Administration later this year for its CE marked NaoTrac robot. Read The Full Article